De gentis Vanorum priscis et hodiernis in Westrogothia sedibus 2

Variantti A.

Physiologia systematis ossium, 1:1:2

Arkit: 1 arkintunnukseton lehti, E-G4 H1. - S. [2] tyhjä.

De angina polyposa 4

Painovuosi nimekkeestä.

Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update

The endothelium plays a vital role in maintaining circulatory homeostasis by the release of relaxing and contracting factors. Any change in this balance may result in a process known as endothelial dysfunction that leads to impaired control of vascular tone and contributes to the pathogenesis of some cardiovascular and endocrine/metabolic diseases. Reduced endothelium-derived nitric oxide (NO) bioavailability and increased production of thromboxane A2, prostaglandin H2 and superoxide anion in conductance and resistance arteries are commonly associated with endothelial dysfunction in hypertensive, diabetic and obese animals, resulting in reduced endothelium-dependent vasodilatation and in increased vasoconstrictor responses. In addition, recent studies have demonstrated the role of enhanced overactivation ofβ-adrenergic receptors inducing vascular cytokine production and endothelial NO synthase (eNOS) uncoupling that seem to be the mechanisms underlying endothelial dysfunction in hypertension, heart failure and in endocrine-metabolic disorders. However, some adaptive mechanisms can occur in the initial stages of hypertension, such as increased NO production by eNOS. The present review focuses on the role of NO bioavailability, eNOS uncoupling, cyclooxygenase-derived products and pro-inflammatory factors on the endothelial dysfunction that occurs in hypertension, sympathetic hyperactivity, diabetes mellitus, and obesity. These are cardiovascular and endocrine-metabolic diseases of high incidence and mortality around the world, especially in developing countries and endothelial dysfunction contributes to triggering, maintenance and worsening of these pathological situations.

De gentis Vanorum priscis et hodiernis in Westrogothia sedibus 2

Variantti B.

De antiquo et hodierno, regni Sveciae imperio

Variantti B.

Voces Pentateuchi Persici 2

Arkit: 1 arkintunnukseton lehti, E-H2. - S. [2] tyhjä.

De transmutatione specierum in regno vegetabili 2

Variantti B.

Ethicae praecipua praecepta & nobiliores plerasque controversias brevibus suis cum explicationibus

Variantti B.

Ethicae praecipua praecepta & nobiliores plerasque controversias brevibus suis cum explicationibus

Variantti A.

De praedictionibus astrologicis

Invokaatio: A.N.O.D.

De Theodosio Magno Romanorum Augusto 2

Invokaatio: S.D.G.

Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes

The purpose of this study was to explore cytokine expression patterns and cytogenetic abnormalities of mesenchymal stem cells (MSCs) from the bone marrow microenvironment of Chinese patients with myelodysplastic syndromes (MDS). Bone marrow samples were obtained from 30 cases of MDS (MDS group) and 30 healthy donors (control group). The expression pattern of cytokines was detected by customized protein array. The karyotypes of MSCs were analyzed using fluorescence in situ hybridization. Compared with the control group, leukemia inhibitory factor, stem cell factor (SCF), stromal cell-derived factor (SDF-1), bone morphogenetic protein 4, hematopoietic stem cell (HSC) stimulating factor, and transforming growth factor-β in the MDS group were significantly downregulated (P<0.05), while interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and programmed death ligand (B7-H1) were significantly upregulated (P<0.05). For chromosome abnormality analysis, the detection rate of abnormal karyotypes (+8, -8, -20, 20q-, -Y, -7, 5q-) was 30% in the MDS group and 0% in the control group. In conclusion, the up- and downregulated expression of these cytokines might play a key role in the pathogenesis of MDS. Among them, SCF and SDF-1 may play roles in the apoptosis of HSCs in MDS; and IFN-γ, TNF-α, and B7-H1 may be associated with apoptosis of bone marrow cells in MDS. In addition, the abnormal karyotypes might be actively involved in the pathogenesis of MDS. Further studies are required to determine the role of abnormal karyotypes in the occurrence and development of MDS.

Migrationes gentium, quatenus divinae Providentiae fatisque rerumpublicarum illustrandis inserviunt

Invokaatio: Q.B.V.D.T.O.M.

Caracterização e processamento de leite bubalino em pó em secador por nebulização

Avaliou-se o processo de secagem por nebulização em "spray dryer" para a obtenção de leite bubalino em pó. Foram realizadas análises físico-químicas no leite in natura e no leite desidratado, para averiguar perdas de macronutrientes ocorridas durante a secagem; análises microbiológicas para assegurar a qualidade higiênico-sanitária do processo e produto e análises sensoriais para estabelecer a aceitabilidade do produto. Foram obtidas isotermas de adsorção e dessorção de umidade a 25°C, para o produto em pó, visando observar o seu comportamento higroscópico. O leite bubalino em pó obtido apresentou como características físicoquímicas: 3,4% de umidade, 23,2% de proteínas, 46,1% de gordura, 4,2% de cinzas, 0,5% de lecitina de soja e 22,6% de carboidratos totais. De acordo com os exames microbiológicos está apto para o consumo humano. O produto foi caracterizado como integral por não ter sofrido qualquer padronização. As perdas ocorridas para a maioria dos macronutrientes durante o processamento, foram inferiores a 5% e apenas o teor de proteínas apresentou variação superior a 15%, devido à desnaturação da caseína em temperatura superior a 80°C. O produto apresentou isotermas de adsorção do tipo III, mesmo comportamento apresentado pelo leite bovino. Através da isoterma de dessorção determinou-se o valor de umidade equivalente à monocamada, obtendo-se o valor médio de 4,4g H2 O/100g b.s., o que validou o processo utilizado. O comportamento de histerese apresentado pelo produto foi similar ao do leite em pó integral, sendo a sua aceitabilidade de 74%, muito próxima a 80% obtido para um leite em pó integral comercial.